Immunovia: Lisa Ford

Pancreatic cancer early detection firm Immunovia has appointed Lisa Ford as its new clinical laboratory director. In that role, Ford will lead lab operations as well as research and development of the next generation of Immunovia's pancreatic cancer test. She has decades of experience leading laboratory project teams through research, development, validation, and implementation of diagnostic tests. She holds a PhD in bioorganic chemistry from Duke University and a BS from the University of California in chemistry. She is also board certified as a high-complexity clinical laboratory director by the American Board of Bioanalysis.